AI SUMMARY — QUBTS is significantly overvalued at $7B market cap with only $2-3M quarterly revenue (P/S of 660), declining YoY revenue, and worsening negative operating cash flow. The post cites lack of insider buying for 3 years and technical setup suggesting retest of $12 and lower, with price target of $4-6 by Jan 27.
| TICKER | QUBTS |
USER | u/natelifts |
| RATING |
BEARISH |
ENTRY |
N/A
|
| POSITION |
N/A
|
BOOK VAL |
N/A |
| CURRENT |
N/A |
P&L % |
N/A
|
| CURR VAL |
N/A |
P&L $ |
N/A
|
This is no more than an absurdly expensive science project that nets 2-3 million quarterly on a whopping 7B market cap. My price target for this is $4-6 by Jan 27.
Technicals look primed for a retest of $12 and lower
P/S 660
Revenue decreasing Y/Y
Insiders haven’t bought their own shares in 3 years, only selling.
Negative operating cash flow increasing 25+% Q/Q